Clinical Trial Update: Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated oxaliplatin and bevacizumab with either fluorouracil plus leucovorin or capecitabine in patients with advanced colorectal cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Prologue Research International | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED